SCHEMBL3148633

SCHEMBL3148633

O=C(CCCCCCc1ccccc1)c1ncc(I)o1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FAAH O00519 16/20 1.00
CES1 P23141 9/20 0.74
NCEH1 Q6PIU2 1/20 0.72
FAAH2 Q6GMR7 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14273017 0.85 FAAH (0.81) FAAHCES1NCEH1
SCHEMBL1471352 0.85 FAAH (1.00) FAAHCES1NCEH1
SCHEMBL3145274 0.84 FAAH (1.00) FAAHCES1NCEH1
SCHEMBL3130534 0.84 FAAH (1.00) FAAHCES1NCEH1
SCHEMBL3140480 0.84 FAAH (1.00) FAAHCES1NCEH1
SCHEMBL3144951 0.84 FAAH (1.00) FAAHCES1NCEH1
SCHEMBL3134547 0.83 FAAH (1.00) FAAHCES1NCEH1
SCHEMBL3144399 0.83 FAAH (1.00) FAAHCES1NCEH1
SCHEMBL4146536 0.82 FAAH (0.69) FAAHCES1
SCHEMBL12344441 0.82 FAAH (0.72) FAAHCES1NCEH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8268817-B2 Substituted oxazole ketone modulators of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2012-09-18 US claimed
US-20100075931-A1 Substituted oxazole ketone modulators of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2010-03-25 US claimed
EP-2068862-A2 SUBSTITUTED OXAZOLE KETONE MODULATORS OF FATTY ACID AMIDE HYDROLASE The Scripps Research Institute (US) 2009-06-17 EP claimed
WO-2008030532-A2 SUBSTITUTED OXAZOLE KETONE MODULATORS OF FATTY ACID AMIDE HYDROLASE THE SCRIPPS RESEARCH INSTITUTE (US) 2008-03-13 WO claimed
US-8268817-B2 Substituted oxazole ketone modulators of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2012-09-18 US disclosed
US-8268817-B2 Substituted oxazole ketone modulators of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2012-09-18 US disclosed
US-8268817-B2 Substituted oxazole ketone modulators of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2012-09-18 US disclosed
US-20100075931-A1 Substituted oxazole ketone modulators of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2010-03-25 US disclosed
US-20100075931-A1 Substituted oxazole ketone modulators of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2010-03-25 US disclosed
US-20100075931-A1 Substituted oxazole ketone modulators of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2010-03-25 US disclosed
EP-2068862-A2 SUBSTITUTED OXAZOLE KETONE MODULATORS OF FATTY ACID AMIDE HYDROLASE The Scripps Research Institute (US) 2009-06-17 EP disclosed
WO-2008030532-A2 SUBSTITUTED OXAZOLE KETONE MODULATORS OF FATTY ACID AMIDE HYDROLASE THE SCRIPPS RESEARCH INSTITUTE (US) 2008-03-13 WO disclosed
WO-2008030532-A2 SUBSTITUTED OXAZOLE KETONE MODULATORS OF FATTY ACID AMIDE HYDROLASE THE SCRIPPS RESEARCH INSTITUTE (US) 2008-03-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075931-A1 Substituted oxazole ketone modulators of fatty acid amide hydrolase FAAH, FAAH2, HCRTR2 FAAH 1/4885CES1 94/4885NCEH1 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.